In the News

As Seen In: Pharmaceutical Commerce

For decades, pharmaceutical companies have relied on a complex network of intermediaries to help patients access medications. But…

As Seen In: Pharmaceutical Executive

New survey highlights growing demand for better patient access.

At this year’s Asembia Specialty Pharmacy Summit, one theme stood out: the growing momentum behind more direct ways…

As Seen In: Authority Magazine

“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…

As Seen In: SHRM

Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.

As Seen In: EBN

On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…

As Seen In: Reuters

Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…

As Seen In: HIT Consultant

Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…

As Seen In: EBN

Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…

As Seen In: Drug Topics

Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…

As Seen In: BenefitsPRO

As healthcare costs continue to burden small businesses, voluntary prescription plans could be a compelling solution for employers…

As Seen In: BenefitsPRO

Prescryptive’s SVP of Payer Solutions, Rae McMahan, offers timely insights in her new article in BenefitsPRO, “With tariffs in…